Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars

NCT00620737 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Company Decision

Conditions

Restrictive Burn Scars of Joint Area

Interventions

BIOLOGICAL: Autologous Human Fibroblasts (Isolagen TherapyTM)
BIOLOGICAL: Placebo

Sponsor

Castle Creek Biosciences, LLC.